The pharmaceutical industry is continuously evolving, with substantial demand for high-performance Active Pharmaceutical Ingredients (APIs). Dulaglutide, a diabetes drug, represents copyrightple of this trend. To meet this demand, US-based manufacturing services are emerging. These companies offer a d